THIS STORY HAS BEEN FORMATTED FOR EASY PRINTING

Senate likely to vote on stalled FDA nomination

Dispute rages over ruling on sales of morning-after pill

By Diedtra Henderson
Globe Staff / August 2, 2006

E-mail this article

Invalid E-mail address
Invalid E-mail address

Sending your article

Your article has been sent.

Text size +

WASHINGTON -- Acting Food and Drug Administration Commissioner Dr. Andrew von Eschenbach has enough supporters for his confirmation to be sent to the full Senate next month, according to a key congressional committee chairman . (Full article: 554 words)

This article is available in our archives:

Globe Subscribers

FREE for subscribers

Subscribers to the Boston Globe get unlimited access to our archives.

Not a subscriber?

Non-Subscribers

Purchase an electronic copy of the full article. Learn More

  • $9.95 1 month archives pass
  • $24.95 3 months archives pass
  • $74.95 1 year archives pass